The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1975, 115: 434-439.
Copyright © 1975 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virelizier, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Virelizier, J.-L.

Host Defenses Against Influenza Virus: The Role of Anti-Hemagglutinin Antibody

Jean-Louis Virelizier1

From the Cell Pathòology Division, Clinical Research Centre, Northwick Park Hospital, Harrow, Middlesex, England, HA1 3UJ

Abstract

In CBA mice the protection provided by transferred immune spleen cells or by antibody has been investigated in immunologically intact, cyclophosphamide-treated and thymus-deprived animals infected with A/PR8 virus. The degree of protection was more closely related to serum antibody levels than to the presence of immune lymphocytes in recipients. Comparison of the protective efficiency of various anti-influenza antisera with different specificities within an influenza A subtype indicated that antibodies recognizing the strain-specific determinants of the influenza hemagglutinin have an important role in protection. Physiologic amounts of transferred antibodies were shown to protect immunodepressed mice, suggesting that, provided a sufficient amount of specific antibodies is secreted, the participation of effectors of cell-mediated immunity is not essential. However, our results suggest that thymusderived lymphocytes have an indirect role in protection by enhancing, through their helper effect, the secretion of anti-influenza antibodies.

Footnotes

1 J V was supported by a fellowship from the Delegation Generale à la Recherche Scientifique et Technique (Paris).




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
T. C. Luke, E. M. Kilbane, J. L. Jackson, and S. L. Hoffman
Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
Ann Intern Med, October 17, 2006; 145(8): 599 - 609.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Baumgarth, O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen
B-1 and B-2 Cell-derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection
J. Exp. Med., July 17, 2000; 192(2): 271 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
F. Kostolanský, E. Varecková, T. Betáková, V. Mucha, G. Russ, and S. A. Wharton
The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin
J. Gen. Virol., July 1, 2000; 81(7): 1727 - 1735.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
L.-a. Pirofski and A. Casadevall
Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Clin. Microbiol. Rev., January 1, 1998; 11(1): 1 - 26.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Murphy, D. Sly, E. Tierney, N. Hosier, J. Massicot, W. London, R. Chanock, R. Webster, and V. Hinshaw
Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys
Science, December 24, 1982; 218(4579): 1330 - 1332.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.